Company
ProstaLund AB
Headquarters: Lund, Sweden
Employees: 7
Market Cap
kr126.8 Million
SEK as of Jan. 1, 2024
US$12.6 Million
ProstaLund AB Categories
Sweden Healthcare Medical Care FacilitiesSweden Healthcare Sweden Medical Care Facilities
Top Competitors by Market Capitalization
Industry: Medical Care Facilities
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
ProstaLund AB has the following listings and related stock indices.
Stock: OMX: PLUN wb_incandescent
Stock: FSX: 7PL wb_incandescent